.jpg)
STAT+: Pharmalittle: Drugmakers agree to negotiate Medicare prices under protest; AstraZeneca settles lawsuits over heartburn drugs
Top of the morning to you, and a fine one it is. Cool breezes and…
Category: Life Sciences
STAT+: Lilly bolts another one on, acquiring Point Therapeutics for $1.4 billion
A couple billion here, a couple billion there, and pretty soon Eli Lilly hopes it…
2023 Nobel Prize winner: Physics award goes to trio for electron breakthroughs
LONDON — Three scientists whose work on electrons widened the world’s understanding of the particles’…
Opinion: How headlines about the RSV antibody injection could cloud parents’ decision-making
As theorists from Samuel Coleridge to Kenneth Burke have noted, language often does our thinking…
As conservative views collide with science, doctors find themselves navigating political landmines
WASHINGTON — It started with a tweet: A year-old, 43-second clip of Kevin Wang talking…
STAT+: Nobel Prize, in a rarity, celebrates a fruitful and durable partnership
The most noteworthy aspect of awarding the Nobel Prize in medicine or physiology to two…
STAT+: Congress extends some pandemic preparedness programs, but not all
WASHINGTON — Congress temporarily extended a few pandemic-preparedness programs when it forestalled a government shutdown…
WHO recommends second malaria vaccine, hoping to address supply issues
Just two years after the World Health Organization’s historic recommendation of the first malaria vaccine,…
STAT+: Verily lands $38 million deal with CDC for wastewater surveillance
Alphabet’s life sciences company Verily has scored its first Centers for Disease Control contract, a…
The stability of $0 premiums in Medicare Advantage
You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow…
STAT+: Court strikes down Trump-era rule that allowed health insurers to broadly use copay accumulators
A U.S. judge has struck down a Trump administration rule that allowed health insurers not…
STAT+: Former FDA official lays out how to keep patients safe from risky medical devices
Madris Kinard’s unlikely journey to becoming a champion for patient safety started in a fire…
Here’s what’s moving the needle in biotech stock, in the final quarter of a dismal year
Want to stay on top of the science and politics driving biotech today? Sign up…
STAT+: Pharmalittle: Court allows Medicare drug price negotiation to proceed; J&J will not enforce patents on key TB drug
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
CDC proposes new antibiotics policy aimed at reducing STIs
The Centers for Disease Control and Prevention is proposing a new policy aimed at dramatically…
STAT+: Syndax’s leukemia drug succeeds in pivotal study
Syndax Pharmaceuticals’ treatment for a genetically defined form of advanced leukemia met its goal in…
STAT+: Mirum’s Chenodal succeeds in late-stage trial for rare metabolic disorder
Mirum Pharmaceuticals reported on Monday that a drug it recently acquired to treat cerebrotendinous xanthomatosis,…
2023 Nobel Prize in Medicine: Karikó, Weissman awarded prize for mRNA research
Two pioneers of mRNA research — the technology that helped the world tame the virus…
STAT+: The biotech scorecard for the fourth quarter: 16 stock-moving events to watch
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the fourth…
Opinion: The new fertility technology IVG is supposed to change everything. Don’t count on it yet
There are times when a new medical technology is thrust into the public spotlight because…
STAT+: What we owe ALS patients — and why one company fell short
What do you say to a patient when the FDA rejects “their” experimental drug —…
STAT+: Obama-era Medicare innovation initiative doesn’t save money after all
WASHINGTON — A key Obama-era initiative was supposed to save Medicare money by testing new…
STAT+: More hospital and outpatient visits expected to persist through fall and winter
Health care providers and health insurance companies are closing the books on their third quarters,…
Can the world still invent an HIV vaccine? Progress in one area creates new problem
Louis Picker is nervous. Last month, the first volunteer was injected with an HIV vaccine…
Bracing for rough respiratory virus season, European officials urge vaccination
LONDON — Health officials in the U.K. and Europe are ramping up their campaigns urging…
STAT+: New lawsuit highlights another wrinkle for settling disputes over surprise medical bills
After Congress officially outlawed surprise medical bills last year, there’s been endless, litigious debate as…
STAT+: Cigna to pay $172 million in Medicare Advantage fraud settlement
Health insurer Cigna is paying more than $172 million to settle allegations that it committed…
STAT+: J&J agrees not to enforce patents on a key tuberculosis drug in dozens of poor countries
In an unexpected turnabout, Johnson & Johnson announced it would not enforce any of its…
GLP-1 drugs are transforming diabetes, obesity and more. Could a Nobel be next?
Next week, 50 medical experts from the Karolinska Institutet in Stockholm will meet to award…
Dianne Feinstein’s struggle with shingles reflects the long increase in cases
The trailblazing life of Senator Dianne Feinstein of California, who died on Friday, covers nearly…
STAT+: Court allows Medicare drug price negotiation to proceed
WASHINGTON — A federal court judge allowed a new Medicare drug price negotiation program to…
STAT+: FDA seeks to regulate lab-developed tests, closing the ‘Theranos loophole’
The Food and Drug Administration on Friday announced its intention to start regulating tests developed…
STAT+: Unitaid slams J&J over pricing and patents for a tuberculosis drug
In a highly unusual move, Unitaid has publicly criticized Johnson & Johnson over its pricing…
STAT+: Generic makers fall short when providing access to low- and middle-income countries, analysis finds
A handful of the largest purveyors of generic medicines have made only halting progress to…
STAT+: Sales from controversial drug discount program rose to $54 billion last year
Prescription medicines purchased in the U.S. under a controversial government discount program amounted to $53.7…
WHO recommends dropping component of many flu vaccines
The World Health Organization has recommended dropping a component of many flu vaccines because the…
STAT+: Pharmalittle: Deadline looms for drugmakers to negotiate with Medicare; GOP senator probes 340B program at two hospitals
And so, another working week will soon draw to a close. Not a moment too…
Women spend 20% more per year on out-of-pocket health costs, says report
Women of all ages pay a total of $15.4 billion more than men on annual…
STAT+: Taysha Gene Therapies’ plan to tackle rare diseases is crumbling
In 2020, as biotech stocks surged amid the pandemic, a startup called Taysha Gene Therapies…
Opinion: AI-driven data analysis could exacerbate misaligned incentives in biomedical research
This summer OpenAI released Code Interpreter, a plug-in for the popular ChatGPT tool that allows…
.jpg)
Survey: Most Cancer Patients Use Complementary or Alternative … – Cancer Therapy Advisor
Survey: Most Cancer Patients Use Complementary or Alternative … Cancer Therapy Advisor Read Original Article: Survey:…
People who use alternative medicine favour risk and novelty, and … – UBC News
People who use alternative medicine favour risk and novelty, and … UBC News Read Original Article:…
KSAT 12: Gardening with KSAT: Looking for aspartame alternative … – UT Health San Antonio
KSAT 12: Gardening with KSAT: Looking for aspartame alternative … UT Health San Antonio Read Original…
Opioid Drug Shortages Affect Patients, Health Systems – Pharmacy Times
Opioid Drug Shortages Affect Patients, Health Systems Pharmacy Times Read Original Article: Opioid Drug Shortages Affect…
STAT+: Brigham and Women’s exec opens up about the Dana-Farber Cancer Institute split, and what it means for the future of cancer care
The severing of ties between two of Boston’s biggest health care giants has placed one…
STAT+: GOP senator probes drug discount programs at Cleveland Clinic, Bon Secours
WASHINGTON — The top ranking Republican on the Senate health committee is launching an investigation…
Listen: Who discovered GLP-1? Plus: BrainStorm at the FDA and biotech’s slump
When is negative data positive enough? Who gets credit for scientific breakthroughs? And wasn’t biotech…
Exodus of life scientists from academia reaches historic levels, new data show
New data released Thursday by the National Science Foundation show the exodus of young life…
STAT+: Drug industry payments to eye docs boosted Medicare spending on pricier treatments
Ophthalmologists who accepted payments from drug companies were less likely to prescribe a cheaper medicine…
She got off dialysis. Her doctor thinks other patients with acute kidney injury can too
SAN FRANCISCO — It was during some of the darkest days of the pandemic —…